600479 千金藥業
按盤價 
12.150 -1.180 (-8.852%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.978 | 10.429 | 9.512 | 13.911 | 13.853 |
| 總資產報酬率 ROA (%) | 3.631 | 6.015 | 4.998 | 6.882 | 6.958 |
| 投入資產回報率 ROIC (%) | 4.919 | 8.650 | 7.767 | 10.714 | 10.758 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.680 | 48.776 | 46.379 | 46.117 | 43.127 |
| 營業利潤率 (%) | 12.205 | 12.049 | 9.150 | 12.161 | 11.034 |
| 息稅前利潤/營業總收入 (%) | 12.215 | 11.506 | 8.492 | 10.960 | 10.990 |
| 淨利潤/營業總收入 (%) | 10.421 | 10.352 | 8.337 | 10.399 | 9.615 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.998 | 87.328 | 93.151 | 95.769 | 92.331 |
| 價值變動淨收益/利潤總額(%) | 5.501 | 10.710 | 4.836 | 3.736 | 4.408 |
| 營業外收支淨額/利潤總額(%) | -0.658 | -0.494 | 0.953 | -0.330 | 0.351 | 償債能力分析 |
| 流動比率 (X) | 1.452 | 1.451 | 2.048 | 2.279 | 2.070 |
| 速動比率 (X) | 1.133 | 1.122 | 1.683 | 1.933 | 1.717 |
| 資產負債率 (%) | 33.011 | 32.506 | 31.103 | 35.283 | 39.217 |
| 帶息債務/全部投入資本 (%) | 14.362 | 14.670 | 13.007 | 17.379 | 21.608 |
| 股東權益/帶息債務 (%) | 574.720 | 559.046 | 646.666 | 456.082 | 345.886 |
| 股東權益/負債合計 (%) | 183.154 | 187.683 | 173.748 | 144.817 | 121.975 |
| 利息保障倍數 (X) | 135.488 | -23.745 | -11.391 | -9.440 | -132.889 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 31.970 | 26.769 | 25.054 | 23.971 | 21.422 |
| 存貨周轉天數 (天) | 91.492 | 94.539 | 94.338 | 99.653 | 90.145 |
| 備註： | 即時報價更新時間為 31/08/2026 16:01 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
